Sort
17,828 grants matching “crispr”
In vivo delivery of CRISPR Cas9-guide RNA nucleoprotein complexes using the nanoPOD platform
$694,345John Christian Tilton · Case Western Reserve University · UG3 · FY2020 · HL
In vivo delivery of CRISPR Cas9-guide RNA nucleoprotein complexes using the nanoPOD platform
$694,345John Christian Tilton · Case Western Reserve University · UG3 · FY2021 · HL
Cholesterol Regulation of Endothelial K+ Channels
$694,203Irena Levitan · University Of Illinois At Chicago · R01 · FY2021 · HL
Reverse Engineering of Cell Senescence
$693,878Marc W Kirschner · Harvard Medical School · R01 · FY2023 · AG
Harnessing mutant IDH1 as a therapeutic target in liver cancer and other solid malignancies
$693,781Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2025 · CA
Mosaic in Vivo Perturbation (MVP) for systematic assessment of gene function in the eye
$693,571Allon Moshe Klein · Harvard Medical School · R01 · FY2024 · EY
Elucidating prostate cancer risk mechanisms through large-scale cistrome wide association studies
$693,457Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Genomic targets of oncoproteins and tumor suppressors
$693,383Kevin Struhl · Harvard Medical School · R01 · FY2019 · CA
Mapping, modeling, and manipulating 3D contacts in vascular cells to connect risk variants to disease genes
$693,228Jesse M Engreitz · Stanford University · R01 · FY2023 · HL
Mapping, modeling, and manipulating 3D contacts in vascular cells to connect risk variants to disease genes
$693,192Jesse M Engreitz · Stanford University · R01 · FY2025 · HL
Elucidating the path to type I IFNs in TB infection
$693,073Amy K Barczak · Massachusetts General Hospital · R01 · FY2024 · AI
A novel mechanism of virulence control in Porphyromonas gingivalis
$692,868Jorge Frias-Lopez · University Of Florida · R01 · FY2021 · DE
Nutrigenomics of Intestinal Vitamin D Action
$692,807Sylvia S Christakos · Rutgers Biomedical And Health Sciences · R01 · FY2024 · DK
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics
$692,783David R Liu · Broad Institute, Inc. · R35 · FY2018 · GM
CRISPR-induced cardiovascular progenitor cells to repair myocardial infarction
$692,459Yigang Wang · University Of Cincinnati · R01 · FY2021 · HL
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics
$692,434David R Liu · Broad Institute, Inc. · R35 · FY2019 · GM
The Genetics of Susceptibility to Mouse Plasma Cell Tumors
$692,220Beverly Mock · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics
$692,073David R Liu · Broad Institute, Inc. · R35 · FY2020 · GM
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
$691,849Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
$691,849Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2021 · CA
Targeting p38 gamma signaling to advance Cutaneous T Cell Lymphoma Therapy
$691,849Steven Terry Rosen · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Pro-Inflammatory Stem Cell Variants in Cystic Fibrosis
$691,846Frank D. McKeon · University Of Houston · R01 · FY2022 · HL
Human gene duplications in neurodevelopment and disease
$691,844Megan Y Dennis · University Of California At Davis · R01 · FY2024 · MH
ETS-family Transcription Factor Mediated Control of Pulmonary Inflammation Induced by Influenza Viruses
$691,840Nicholas S Heaton · Duke University · R01 · FY2025 · AI
Human Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling
$691,803Joseph C Wu · Stanford University · R01 · FY2023 · HL